Palladium Partners’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$2.15M Hold
41,800
0.09% 138
2021
Q4
$2.09M Sell
41,800
-118
-0.3% -$5.84K 0.09% 143
2021
Q3
$2.02M Hold
41,918
0.09% 136
2021
Q2
$2.21M Buy
41,918
+92
+0.2% +$4.8K 0.1% 128
2021
Q1
$2.07M Buy
+41,826
New +$2.01M 0.1% 127
2014
Q2
Sell
-100
Closed -$5K 435
2014
Q1
$5K Buy
+100
New +$5.06K ﹤0.01% 511
2013
Q4
Sell
-100
Closed -$5K 442
2013
Q3
$5K Sell
100
-4,400
-98% -$224K ﹤0.01% 519
2013
Q2
$232K Buy
+4,500
New +$240K 0.02% 225

Other funds holding SNY

Palladium Partners's SNY Position: Q1 2022 in Review

Palladium Partners held its Sanofi (SNY) position steady in Q1 2022 at 41,800 shares worth $2.15M. The position accounts for 0.09% of the portfolio, ranked #138.

Palladium Partners first reported a position in SNY in Q2 2013 and has held it in 8 quarters since. The position peaked at $2.21M in Q2 2021. 623 funds tracked by Wall St. Rank hold SNY as of Q1 2022.

  • Palladium Partners held 41,800 shares of Sanofi worth $2.15M as of Q1 2022.
  • Palladium Partners left its Sanofi share count unchanged in Q1 2022.
  • Sanofi made up 0.09% of Palladium Partners's portfolio in Q1 2022, its #138 holding.
  • Palladium Partners first reported a position in Sanofi in Q2 2013 and has held it in 8 quarters since.
  • Palladium Partners's Sanofi position peaked at $2.21M in Q2 2021.
  • 623 funds tracked by Wall St. Rank held Sanofi as of Q1 2022.

Based on Palladium Partners's 13F filing for Q1 2022, filed 26 Apr 2022.